English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, December 15, 2020
德琪醫藥中長線價值俱佳 未來兩年陸續收成
Friday, November 20, 2020
覆蓋亞太地區的一體化創新腫瘤藥公司德琪醫藥有限公司於香港聯合交易所主板掛牌
Antengene Corporation Successfully Listed on Main Board of SEHK
Monday, July 20, 2020
德琪醫藥C輪融資9700萬美元,主要用於新藥研發和商業化
德琪医药C轮融资9700万美元,主要用于新药研发和商业化
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575